Copyright
©The Author(s) 2025.
World J Clin Cases. Jul 26, 2025; 13(21): 104723
Published online Jul 26, 2025. doi: 10.12998/wjcc.v13.i21.104723
Published online Jul 26, 2025. doi: 10.12998/wjcc.v13.i21.104723
Table 3 Common indications for genetic testing for hereditary alpha tryptasemia
sBT level ≥ 8 ng/mL |
Recurrent signs of MC activation with unclear etiology (such as idiopathic anaphylaxis) |
Suspected SM with negative c-KIT D816V, but very high TPS level |
SM or MCAS with severe mediator-related symptoms |
Serum TPS value > 15.0 ng/mL without underlying mastocytosis or myeloid neoplasm |
Familial clustering of systemic MC activation symptoms |
Higher levels of sBT according to the degree of bone marrow mast cell infiltration |
Diagnosed or suspected idiopathic or secondary MCAS |
- Citation: Tüsüz Önata E, Özdemir Ö, Savaşan S. Hereditary alpha tryptasemia and clinical implications. World J Clin Cases 2025; 13(21): 104723
- URL: https://www.wjgnet.com/2307-8960/full/v13/i21/104723.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i21.104723